All News

Senate asks CMS to reconsider ESA coverage decision

Data on infection and death rates at New York City's hospitals is being publicly released

With biologic costs zooming, it's time for biogenerics to be approved, says Hospira CEO.

An employer group finds that 13 pharmacy benefit managers are willing to operate transparently in their drug contracting dealings with their clients.

Healthcare report card provides data on quality of hospital care, mortality rates at hospitals in New York and New Jersey.

Investigational drug may provide new approach to treating schizophrenia.

FDA warns Melanocorp over illegal sale of Melanotan II

Consumer Reports warns that off-label use of anticonvulsants may not be the best initial treatment and is expensive.

A new white paper contends that GPOs charge too much for their administrative fees.

Blue Cross Blue Shield of Michigan has begun paying for OTC Prilosec and is encouraging a switch to Prilosec OTC or generic Prilosec for eligible members using the prescription drug Nexium.

AAP endorses new recommendations on dental procedure antibiotics.

Shire recalls some Daytrana (methylphenidate transdermal system) ADHD patches.

Medicare announces it will offer reimbursement for use of infusion pump for subcutaneous immune globulin.

Pharmacists offer opinions on dextromethorphan restrictions in August Drug Topics on-line poll.

ACAM2000 smallpox vaccine receives FDA approval.

ACAM2000 smallpox vaccine receives FDA approval.

Researchers have found that patients that used statin drugs had fewer signs associated with Alzheimer's disease. Statins may impact Alzheimer's patients

Children are getting vaccinated at record levels, while adolescents' rates are below goals.

Pharmacist indicted for illegally importing human growth hormone.

University and pharmaceutical firm create program to detect and better understand adverse drug reactions.

Doctors treating cancer patients want CMS to ease rules restricting coverage of anemia drugs.

The ASI-MV is one of several tools that Inflexxion uses to provide real-time, product-specific data to substance-abuse facilities nationwide. The tools are part of the National Addictions Vigilance Intervention and Prevention Program (NAVIPPRO), a system designed to shed more light on substance-abuse issues and prescription painkiller addictions.

A drug with a new mechanism of action is always a welcome addition in the fight against HIV. Maraviroc was recently approved by the FDA and is the first of the chemokine receptor 5 antagonists to enter the market.

Several healthcare groups involved in making and dispensing pharmaceuticals have partnered to create Rx Response-a program designed to help support the continued delivery of drugs during a public health emergency.

Reclast (zoledronic acid injection, Novartis) has been approved by the FDA as the first once-yearly treatment for women with postmenopausal osteoporosis.

Information on how genetic variations can affect a patient's response to warfarin must now be included on the drug's label, according to the FDA.

"Fast start, slow finish." That's how Douglas Long characterized the U.S. pharmaceutical market over the past year, ending in June 2007.

The FDA has proposed a new regulation that sets standards for OTC sunscreen products.